Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Empros Pharma AB
AB
Active
Org 5569453862
Nanna Svartz Väg 4, 171 65
Solna
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 12 years old
5-9 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Empros Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
14M
27M
41M
54M
0M
2020
0M
2021
0M
2022
47M
2023
8M
2024
EBITDA
SEK millions
0M
-4M
-8M
-11M
-15M
-7M
2020
-12M
-71%
2021
-9M
+25%
2022
-12M
-33%
2023
-12M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
46 521
7 973
Staff expenses
—
—
—
−4 121
−2 746
EBITDA
−6 578
−11 869
−9 213
−11 687
−12 105
Depreciation & amort.
−0
−0
−0
—
—
EBIT
−6 578
−11 869
−9 213
−11 687
−12 105
Net financials
1
2
36
1 358
470
Profit before tax
−6 578
−11 868
−9 177
−10 330
−11 635
Tax
−0
−0
−0
—
—
Net profit
−6 578
−11 868
−9 177
−10 330
−11 635
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
53 948
57 656
76 665
147 266
129 574
Equity
52 393
56 203
71 890
140 133
128 498
Long-term debt
0
0
0
—
—
Short-term debt
1 555
1 452
4 775
7 132
1 076
Total debt
1 555
1 452
4 775
7 132
1 076
Financial ratios
5-year trend
EBITDA-margin
-151.8%
This company
15.8%
Market median
-1061% vs market
2020
2024
Soliditetsgrad
99.2%
This company
38.2%
Market median
+160% vs market
2020
2024
Egenkapitalforrentning
-9.1%
This company
18.4%
Market median
-149% vs market
2020
2024
Nettoresultatgrad
-145.9%
This company
8.1%
Market median
-1901% vs market
2020
2024
Aktivomsætning
0.06×
This company
1.12×
Market median
-95% vs market
2020
2024
Gæld/egenkapital
0.01×
This company
0.62×
Market median
+98% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Empros Pharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
